GEORGE A. VRANEY, M.D.
This content is PDF only. Please click on the PDF icon to access.
To the editor: The article by Colonel Bird and associates in the June issue (Ann Intern Med 86:799-802, 1977) on the treatment of tuberculosis by a nonpulmonary physician made important points on this problem. Its recommendation on the deletion of the use of isoniazid (INH) in cases of resistant or suspected resistant tuberculosis remains, however, controversial.
Although clearly INH should not be considered one of the "good drugs" used in the treatment of patients with INH-resistant tuberculosis, either suspected or documented by sensitivity studies, there are three reasons why INH should be used with the other appropriate medications. The first
VRANEY GA. Drugs for Tuberculosis. Ann Intern Med. 1977;87:381–382. doi: https://doi.org/10.7326/0003-4819-87-3-381_2
Download citation file:
Published: Ann Intern Med. 1977;87(3):381-382.
Copyright © 2020 American College of Physicians. All Rights Reserved.
Print ISSN: 0003-4819 | Online ISSN: 1539-3704
Conditions of Use